CDK4/6 inhibitors are used to treat certain types of breast cancer. They work by slowing the growth of cancer cells by inhibiting the CDK4 and CDK6 enzymes that play a role in cell division.
RIBOCICLIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
TRILACICLIB prevents low levels of red blood cells, white blood cells, and platelets caused by chemotherapy. It works by protecting the cells in your bone marrow that make these blood cells. This lowers the risk of infection and bleeding. It also reduces the need for blood transfusions.
PALBOCICLIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
ABEMACICLIB treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up